CRIS Curis, Inc.
$0.38▲ +2.35%
Healthcare
Other
Volume 53.4K
Avg Volume (10D) 327.1K
Key Metrics & Fundamentals
Market Cap
$930,744
P/E Ratio
0.3
Div Yield
0.00%
52W Range
0.33 - 31.80
% vs 50 MA
-62.91%
% vs 200 MA
-95.98%
RSI-14
12.3
MACD Histogram
+0.0300
Beta (1Y vs SPY)
1.93
Free Cash Flow
-$9.65M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$11.23M
COGS
$0
Operating Exp
$9.94M
Operating Income
-$9.94M
EBIT
-$9.94M
Pretax Income
-$8.58M
Net Income
-$8.58M
EPS (Diluted)
-4.02
Price & Volume History
Loading chart…
Recent News
Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors
PR Newswire · Oct 16, 2026 8:00 AM ET
VISTA Inhibitor Market Insights Report 2026 | Featuring Profiles of Aurigene Discovery Technologies, Curis, Hummingbird Bioscience, Kineta, PharmAbcine
GlobeNewswire · Aug 26, 2026 10:16 AM ET
Curis: Q2 Earnings Snapshot
Associated Press · Aug 14, 2026 4:16 PM ET
Curis Prices $5.6 Million Public Offering With Healthcare-Focused Institutional Investors
MT Newswires · Aug 13, 2026 9:28 AM ET
Curis, Inc. Announces Pricing of $5.6 Million Public Offering
PR Newswire · Aug 13, 2026 8:00 AM ET
Curis (CRIS) Stock Fair Value Moves Lower After Emavusertib TakeAim Model Rework
Simply Wall St. · Aug 5, 2026 1:11 PM ET
Curis Doses First Five Patients in TakeAim CLL Study
PR Newswire · Jul 30, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Dec 2025
See CRIS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.